Olympus (TYO:7733) announced today that it entered into a strategic distribution agreement with EndoClot Plus. EndoClot Plus develops technologies in the hemostasis space, including the EndoClot PHS — a nonthermal, nontraumatic method for achieving hemostasis with GI bleeds designed to help gastroenterologists stop bleeding rapidly and reliably. The biomaterial therapeutic solution developer is based in […]
EndoClot Plus
FDA approves EndoClot hemostat for GI bleeding
EndoClot Plus this week announced that it has received FDA approval for its EndoClot Polysaccharide Hemostatic System (PHS). EndoClot PHS is a nonthermal, nontraumatic method for achieving hemostasis with GI bleeds and is designed to help gastroenterologists stop bleeding rapidly and reliably. The single-use device has a starch-based powder hemostat that is applied directly to […]